Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001415889-25-007887

Director acquired 2,908 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Holder Michael Director 2025-03-10 Option exercise +2,908 6,543 D
Derivatives
Holder Michael Director 2025-03-10 Option exercise · Restricted Stock Units −2,908 19,635 D
Loading xslF345X05/form4-03122025_090354.xml…